Genome Editing Technology

Selected news for Genome Editing Technology, representing 7% of data collected since 10/2017. Recent stories appear in ZDNet and boingboing.net. This healthcare topic shares news with CRISPR, Precision BioSciences, LogicBio Therapeutics and many others.

Please provide a valid email address.

Selected Headines

Date Headline (link) Source Relevant Snippet
10/10/2020 Australian and New Zealand scientists use AI to predict heart disease risk ZDNet Scribe Therapeutics Inc. co-founder Jennifer Doudna, Ph.D., has been awarded the 2020 Nobel Prize in Chemistry along with collaborator Emmanuelle Charpentier, Ph.D., for their discovery of CRISPR, the genome editing technology that has transformed modern science and biomedicine. The two scientists are the first women to jointly win a Nobel Prize.Doudna published her initial work on the CRISPR-Cas9 system and its potential for rewriting the DNA of ...
10/1/2020 Call for a Citizens’ Assembly to Help Govern Genome Editing genengnews.com If you like the idea of juries weighing evidence and delivering verdicts, you might also like the idea of global citizens’ assemblies deliberating over genome editing technology . Both juries and citizen’s assemblies reflect the same democratic impulse: the desire to expand the circle of decision-makers to include people from all walks of life, not just the highly credentialed. Everyone, the highly credentialed and the rest of us, will live ...
9/29/2020 malvern-online.com Qihan Biotech, a leader in applying genome editing technology to cell therapies and organ transplantation, today announced the expansion of its Scientific Advisory Board to include a total of 12 world-renowned experts in synthetic biology, regenerative medicine, transplantation immunology and cell therapy, as well as the formation of several Scientific Advisory Committees. Qihan was founded in 2018 to develop novel cell and organ therapies using multiplexable genome editing and ...
9/29/2020 Qihan Biotech Expands Scientific Advisory Board and Establishes Scientific Advisory Committees Benzinga Qihan Biotech, a leader in applying genome editing technology to cell therapies and organ transplantation, today announced the expansion of its Scientific Advisory Board to include a total of 12 world-renowned experts in synthetic biology, regenerative medicine, transplantation immunology and cell therapy, as well as the formation of several Scientific Advisory Committees. Qihan was founded in 2018 to develop novel cell and organ therapies using multiplexable genome editing and ...
9/29/2020 Qihan Biotech Expands Scientific Advisory Board and Establishes Scientific Advisory Committees firstwordpharma.com Qihan Biotech Expands Scientific Advisory Board and Establishes Scientific Advisory Committees (Ref: Business Wire) Print HANGZHOU, China--( BUSINESS WIRE )-- Qihan Biotech, a leader in applying genome editing technology to cell therapies and organ transplantation, today announced the expansion of its Scientific Advisory Board to include a total of 12 world-renowned experts in synthetic biology, regenerative medicine, transplantation immunology and cell therapy, as well as the formation of several Scientific ...
9/29/2020 Qihan Biotech Expands Scientific Advisory Board and Establishes Scientific Advisory Committees BioSpace HANGZHOU, China--( BUSINESS WIRE )-- Qihan Biotech, a leader in applying genome editing technology to cell therapies and organ transplantation, today announced the expansion of its Scientific Advisory Board to include a total of 12 world-renowned experts in synthetic biology, regenerative medicine, transplantation immunology and cell therapy, as well as the formation of several Scientific Advisory Committees. Qihan was founded in 2018 to develop novel cell and organ therapies using ...
9/29/2020 Qihan Biotech Expands Scientific Advisory Board and Establishes Scientific Advisory Committees financialbuzz.com Qihan Biotech, a leader in applying genome editing technology to cell therapies and organ transplantation, today announced the expansion of its Scientific Advisory Board to include a total of 12 world-renowned experts in synthetic biology, regenerative medicine, transplantation immunology and cell therapy, as well as the formation of several Scientific Advisory Committees.Qihan was founded in 2018 to develop novel cell and organ therapies using multiplexable genome editing and ...
9/28/2020 S Korean firm specialising in life science technology to set ground in Qatar gulf-times.com ... genome editing, CRISPR PLUS technology,” the company said in a statement. G+FLAS, which is based in South Korea, was founded in 2014 by its CEO, Dr Sunghwa Choe, and specialises in CRISPR-Cas genome editing technology and applicational technology development; product development and production of biomedicine, and anti-cancer drugs, among others; plant-derived pharmaceuticals; genetic disease treatment; precision targeted therapy; CRISPR Cancerase; non-GMO; novel seed for arid ...
9/21/2020 Precision BioSciences and SpringWorks Therapeutics Announce Clinical Collaboration to Evaluate PBCAR269A in Combination with Nirogacestat in Patients with Relapsed or Refractory Multiple Myeloma Globe Newswire ... a pipeline of cell-phenotype optimized allogeneic CAR T therapies derived from healthy donors and then modified via a simultaneous TCR knock-out and CAR T knock-in step with the Company’s proprietary ARCUS ® genome editing technology . Precision BioSciences optimizes its CAR T therapy candidates for immune cell expansion in the body by maintaining a high proportion of naïve and central memory CAR T cells. The U.S. Food and Drug ...
9/20/2020 India's first CRISPR COVID-19 test Feluda approved for use sakaltimes.com ... and 98 per cent specificity for detecting novel coronavirus. The test uses an indigenously developed, cutting-edge CRISPR technology for detection of the genomic sequence of the SARS-CoV-2 virus. CRISPR is a genome editing technology for diagnosing diseases. The Tata CRISPR test is the world's first diagnostic test to deploy a specially adapted Cas9 protein to successfully detect the virus causing Covid-19. This marks a significant achievement ...
9/20/2020 'Feluda' Covid test: DCGI nod to commercial launch 24x7livenewz.com ... 2 virus, CSIR said in a statement. The Tata CRISPR test achieves accuracy levels of traditional RT-PCR tests with quicker turnaround time, less expensive equipment and better ease of use. CRISPR is a genome editing technology to diagnose diseases. The technology has been developed by CSIR-IGIB (Institute of Genomics and Integrative Biology). “The Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) test, powered by CSIR-IGIB (Institute of ...
9/20/2020 Drug Controller Approves Commercial Launch Of Low Cost Covid Test "Feluda" blogspot.com ... 2 virus, CSIR said in a statement. The Tata CRISPR test achieves accuracy levels of traditional RT-PCR tests with quicker turnaround time, less expensive equipment and better ease of use. CRISPR is a genome editing technology to diagnose diseases. The technology has been developed by CSIR-IGIB (Institute of Genomics and Integrative Biology). "The Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) test, powered by CSIR-IGIB (Institute of ...
9/20/2020 India's first CRISPR Covid-19 test approved for use newkerala.com ... and 98 per cent specificity for detecting novel coronavirus. The test uses an indigenously developed, cutting-edge CRISPR technology for detection of the genomic sequence of the SARS-CoV-2 virus. CRISPR is a genome editing technology for diagnosing diseases.The Tata CRISPR test is the world's first diagnostic test to deploy a specially adapted Cas9 protein to successfully detect the virus causing Covid-19.This marks a significant achievement for ...
9/19/2020 India’s first CRISPR Covid-19 test approved for use npnews24.com ... sensitivity and 98 per cent specificity for detecting novel coronavirus.The test uses an indigenously developed, cutting-edge CRISPR technology for detection of the genomic sequence of the SARS-CoV-2 virus. CRISPR is a genome editing technology for diagnosing diseases.The Tata CRISPR test is the world’s first diagnostic test to deploy a specially adapted Cas9 protein to successfully detect the virus causing Covid-19.This marks a significant achievement for ...
9/19/2020 India's first CRISPR Covid-19 test approved for use daijiworld.com ... and 98 per cent specificity for detecting novel coronavirus. The test uses an indigenously developed, cutting-edge CRISPR technology for detection of the genomic sequence of the SARS-CoV-2 virus. CRISPR is a genome editing technology for diagnosing diseases. The Tata CRISPR test is the world's first diagnostic test to deploy a specially adapted Cas9 protein to successfully detect the virus causing Covid-19. This marks a significant achievement ...
9/19/2020 India’s first CRISPR Covid-19 test developed by the Tata Group and CSIR-IGIB – Approved for use in India ibgnews.com ... with 96% sensitivity and 98% specificity for detecting the novel coronavirus. This test uses an indigenously developed, cutting-edge CRISPR technology for detection of the genomic sequence of SARS-CoV-2 virus.CRISPR is a genome editing technology to diagnosing diseases. The Tata CRISPR test is the world’s first diagnostic test to deploy a speciallyadapted Cas9 protein to successfully detect the virus causing Covid-19. This marks a significant achievement for ...
9/19/2020 Drug Controller Approves Commercial Launch Of Low Cost Covid Test Feluda ndtv.com ... 2 virus, CSIR said in a statement. The Tata CRISPR test achieves accuracy levels of traditional RT-PCR tests with quicker turnaround time, less expensive equipment and better ease of use. CRISPR is a genome editing technology to diagnose diseases. The technology has been developed by CSIR-IGIB (Institute of Genomics and Integrative Biology). "The Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) test, powered by CSIR-IGIB (Institute of ...
9/19/2020 India’s first CRISPR Covid-19 test approved for use twistarticle.com ... and 98 per cent specificity for detecting novel coronavirus. The test uses an indigenously developed, cutting-edge CRISPR technology for detection of the genomic sequence of the SARS-CoV-2 virus. CRISPR is a genome editing technology for diagnosing diseases. ADVERTISEMENT The Tata CRISPR test is the world's first diagnostic test to deploy a specially adapted Cas9 protein to successfully detect the virus causing Covid-19. This marks a significant ...
9/17/2020 Precision BioSciences and Servier Expand CAR T Oncology Development Collaboration with Four New Programs Targeting Hematological and Solid Tumors Globe Newswire ... designed to maximize the number of patients who can potentially benefit from CAR T therapy. Precision carefully selects high-quality T cells derived from healthy donors as starting material, then utilizes its unique ARCUS genome editing technology to modify the cells via a single-step engineering process. By inserting the CAR gene at the T cell receptor (TCR) locus, this process knocks in the CAR while knocking out the TCR ...
9/16/2020 Scientists update genome editing technology Phys Org ... delivery problem for therapeutic genome editing: Current status and perspective of non-viral methods, Biomaterials (2020). DOI: 10.1016/j.biomaterials.2020.120282 Journal information: Provided by Peter the Great Saint-Petersburg Polytechnic University Citation : Scientists update genome editing technology (2020, September 16) scientists-genome-technology.html ...